Literature DB >> 24176425

Clinical neurogenetics: huntington disease.

Yvette M Bordelon1.   

Abstract

Huntington disease (HD) is an autosomal dominant, adult-onset, progressive neurodegenerative disease characterized by the triad of abnormal movements (typically chorea), cognitive impairment, and psychiatric problems. It is caused by an expanded CAG repeat in the gene encoding the protein huntingtin on chromosome 4 and causes progressive atrophy of the striatum as well as cortical and other extrastriatal structures. Genetic testing has been available since 1993 to confirm diagnosis in affected adults and for presymptomatic testing in at-risk individuals. This review covers HD signs, symptoms, and pathophysiology; current genetic testing issues; and current and future treatment strategies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAG repeat disorder; Huntingtin; Preimplantation genetic diagnosis; Presymptomatic genetic testing; Striatum; Tetrabenazine

Mesh:

Year:  2013        PMID: 24176425     DOI: 10.1016/j.ncl.2013.05.004

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  5 in total

Review 1.  Parkinsonism and inborn errors of metabolism.

Authors:  A Garcia-Cazorla; S T Duarte
Journal:  J Inherit Metab Dis       Date:  2014-06-07       Impact factor: 4.982

2.  Pallidal deep brain stimulation in juvenile Huntington's disease: local field potential oscillations and clinical data.

Authors:  Stefano Ferrea; Stefan J Groiss; Saskia Elben; Christian J Hartmann; Steve B Dunnett; Anne Rosser; Carsten Saft; Alfons Schnitzler; Jan Vesper; Lars Wojtecki
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

3.  Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task.

Authors:  Thomas Hunefeldt; Sabrina Maffi; Simone Migliore; Ferdinando Squitieri; Marta Olivetti Belardinelli
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

4.  Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington's Disease.

Authors:  Daniel O Claassen; Jonathan DeCourcy; Jennifer Mellor; Charlotte Johnston; Ravi G Iyer
Journal:  J Health Econ Outcomes Res       Date:  2021-06-21

5.  The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care.

Authors:  Karen L Kaul; Linda M Sabatini; Gregory J Tsongalis; Angela M Caliendo; Randall J Olsen; Edward R Ashwood; Sherri Bale; Robert Benirschke; Dean Carlow; Birgit H Funke; Wayne W Grody; Randall T Hayden; Madhuri Hegde; Elaine Lyon; Kazunori Murata; Melissa Pessin; Richard D Press; Richard B Thomson
Journal:  Acad Pathol       Date:  2017-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.